Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Traumatic Brain Injury Enhances Susceptibility to Lung Bacterial Infection in Mice and Pigs by Modulating the Innate Immune Response.

Critical care medicine·2026
Same author

Altered monocyte and NK cell phenotypes correlate with posttrauma infection.

The journal of trauma and acute care surgery·2019
Same author

Using a Model of Analysts' Judgments to Augment an Item Calibration Process.

Educational and psychological measurement·2018
Same author

Complement Activation in Trauma Patients Alters Platelet Function.

Shock (Augusta, Ga.)·2016
Same author

Effects of fluid administration on renal perfusion in critically ill patients.

Critical care (London, England)·2015
Same author

Talactoferrin in Severe Sepsis: Results From the Phase II/III Oral tAlactoferrin in Severe sepsIS Trial.

Critical care medicine·2015
Same journal

Obesity: biomechanical implications for mechanical ventilation.

Critical care (London, England)·2026
Same journal

Combined trauma and toxic inhalation in war and disaster medicine: alveolar-capillary barrier failure and respiratory countermeasures.

Critical care (London, England)·2026
Same journal

The molecular ICU: a primer on omics, informatics and the future of precision critical care.

Critical care (London, England)·2026
Same journal

Bilateral radial arterial pressure concordance as a real-time bedside marker of native cardiac recovery during peripheral VA-ECMO weaning.

Critical care (London, England)·2026
Same journal

Beyond shear stress: septic microvascular failure remains a multifactorial phenomenon.

Critical care (London, England)·2026
Same journal

Anticoagulation-free VV-ECMO: expanding the evidence beyond trauma.

Critical care (London, England)·2026
See all related articles

Related Experiment Video

Updated: May 28, 2026

Integrated Compensatory Responses in a Human Model of Hemorrhage
07:57

Integrated Compensatory Responses in a Human Model of Hemorrhage

Published on: November 20, 2016

Massive bleeding in polytrauma: how can we make progress?

Jean-Louis Vincent1, Richard Dutton, Michael Parr

  • 1Department of Intensive Care, Erasme Hospital, UniversitĂ© Libre de Bruxelles, Route de Lennik 808, 1070 Brussels, Belgium. jlvincen@ulb.ac.be

Critical Care (London, England)
|October 15, 2011
PubMed
Summary
This summary is machine-generated.

Hemorrhage control in trauma is critical. While recombinant human factor VIIa reduces transfusions, its impact on survival in modern trauma care is unclear due to lower mortality rates and high patient number requirements for studies.

More Related Videos

A Saline/Bipolar Radiofrequency Energy Device As an Adjunct for Hemostasis in Solid Organ Injury/Trauma
04:20

A Saline/Bipolar Radiofrequency Energy Device As an Adjunct for Hemostasis in Solid Organ Injury/Trauma

Published on: July 28, 2020

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

Related Experiment Videos

Last Updated: May 28, 2026

Integrated Compensatory Responses in a Human Model of Hemorrhage
07:57

Integrated Compensatory Responses in a Human Model of Hemorrhage

Published on: November 20, 2016

A Saline/Bipolar Radiofrequency Energy Device As an Adjunct for Hemostasis in Solid Organ Injury/Trauma
04:20

A Saline/Bipolar Radiofrequency Energy Device As an Adjunct for Hemostasis in Solid Organ Injury/Trauma

Published on: July 28, 2020

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

Area of Science:

  • Trauma care
  • Hemorrhage management
  • Pharmacological interventions

Background:

  • Trauma remains a leading cause of global mortality, with hemorrhage accounting for approximately 30% of trauma-related deaths.
  • Effective bleeding control is a cornerstone of trauma patient management.
  • Recombinant human factor VIIa (rFVIIa) is utilized off-label for massive hemorrhage, with trials showing reduced transfusion needs.

Purpose of the Study:

  • To discuss the challenges in evaluating interventions for severely bleeding trauma patients.
  • To explore strategies for advancing the management of massive hemorrhage in contemporary trauma care.

Main Methods:

  • Commentary reflecting on existing evidence and clinical practice.
  • Discussion of the impact of improved general trauma care on outcome studies.
  • Consideration of statistical power and patient recruitment challenges in clinical trials.

Main Results:

  • Recombinant human factor VIIa has been shown to decrease blood transfusions in massively bleeding trauma patients.
  • Improved overall trauma care has led to lower mortality rates, complicating the assessment of specific interventions' impact on survival.
  • High patient numbers and long recruitment periods are significant hurdles for demonstrating survival benefits.

Conclusions:

  • Demonstrating the survival benefit of interventions like rFVIIa in severely bleeding trauma patients is challenging due to declining mortality rates.
  • Future research and management strategies must adapt to the evolving landscape of trauma care to effectively assess and improve patient outcomes.